P2.01-043 PD-L1 Expression, EGFR and KRAS Mutations in...

Journal of Thoracic Oncology 2017 / 11 Vol. 12; Iss. 11

P2.01-043 PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients

Cronin-Fenton, D., Dalvi, T., Hedgeman, E., Norgaard, M., Petersen, L., Hansen, H., Fryzek, J., Lawrence, D., Walker, J., Mellemgaard, A., Rasmussen, T., Shire, N., Rigas, J., Potter, D., Hamilton-Dut
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.1145
Date:
November, 2017
File:
PDF, 581 KB
english, 2017
Conversion to is in progress
Conversion to is failed